Enterome Reports Positive Phase 2 EO2463 Results
Paris, France | July 21, 2026 Enterome SA announced positive interim Phase 1/2 clinical data from its ongoing SIDNEY...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Paris, France | July 21, 2026 Enterome SA announced positive interim Phase 1/2 clinical data from its ongoing SIDNEY...
HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...
